Kelly L. Covert

Bacteremia and Infective Endocarditis
Chastain, D. B., Cluck, D. & Covert, K. L., Jun 2025, DiPiro’s Pharmacotherapy: A Pathophysiologic Approach, 13th Edition. 13 ed.
Research output: Chapter in Book/Report/Conference proceeding › Chapter
Cefepime-Enmetazobactam: A Drug Review of a Novel Beta-Lactam/Beta-Lactamase Inhibitor
Lanier, C., Melton, T. & Covert, K., Jun 2025, In: Annals of Pharmacotherapy. 59, 6, p. 570-576 7 p.
Research output: Contribution to journal › Review article › peer-review
Incidence and potential predictors of SGLT2 inhibitor initiation in acutely hospitalized patients with heart failure
Lanier, C., Brumit, J. C., Tharp, J., Crawford, J., White, K. M., Wilson, V. & Covert, K., Jul 1 2025, In: American Journal of Health-System Pharmacy. 82, 13, p. e624-e631
Research output: Contribution to journal › Article › peer-review
Pivmecillinam for Uncomplicated Acute Cystitis: A Contemporary Review
Burchette, J. E., Covert, K., Tu, P., White, B. P., Chastain, D. B. & Cluck, D. B., Aug 2025, In: Annals of Pharmacotherapy. 59, 8, p. 743-757 15 p.
Research output: Contribution to journal › Review article › peer-review
Proton Pump Inhibitor Use in Patients With Cirrhosis and Its Association With Spontaneous Bacterial Peritonitis
Thomas, M., Lanier, C. & Covert, K., 2025, (Accepted/In press) In: Journal of Pharmacy Technology. 87551225251364516.
Research output: Contribution to journal › Article › peer-review

Research output